Alternate-day fasting appears to be an effective diet therapy for individuals with NAFLD that can achieve weight loss and improvement of dyslipidaemia.

PMID: 

BMC Gastroenterol. 2019 Dec 18 ;19(1):219. Epub 2019 Dec 18. PMID: 31852444

Abstract Title: 

Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial.

Abstract: 

BACKGROUND: Alternate-day fasting (ADF) is a novel diet therapy that may achieve reduction in body weight and improvement of dyslipidaemia, but the impact of this diet on patients with non-alcoholic fatty liver disease (NAFLD) remains unknown. The aim of this study was to evaluate the effects of ADF on the body weight and lipid profile of individuals with NAFLD.METHODS: NAFLD patients (n = 271) were randomised to the ADF group, time-restricted feeding (TRF) group, or the control group and subjected to the respective diet for 12 weeks. Anthropometric measurements (body weight, fat mass/fat-free mass) were performed, and plasma lipids were analysed enzymatically.RESULTS: Within 4 weeks, the body weight decreased significantly (P 

read more